These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 39414281)

  • 1. Association of regular plasmapheresis donation with serum protein and electrolyte levels: a multicentre cross-sectional study in China.
    Xiao G; Li C; Chen Y; Song W; Yang H; Yang Y; Zhang Y; Pu Z; Wang X; Xie S; Yang S; Zeng J; Li W; Wang Y
    BMJ Open; 2024 Oct; 14(10):e085786. PubMed ID: 39414281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors (SIPLA).
    Schulzki T; Seidel K; Storch H; Karges H; Kiessig S; Schneider S; Taborski U; Wolter K; Steppat D; Behm E; Zeisner M; Hellstern P;
    Vox Sang; 2006 Aug; 91(2):162-73. PubMed ID: 16907878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risks of low hemoglobin deferral in a large retrospective cohort of plasmapheresis donors and the influence factors of return for a subsequent donation in China.
    Xiao G; Dong D; Wang Y; Li C; Huang GT; Yang H; Huang J; Chen F
    PeerJ; 2023; 11():e14999. PubMed ID: 36935911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective trial on the safety of long-term intensive plasmapheresis in donors.
    Bechtloff S; Tran-My B; Haubelt H; Stelzer G; Anders C; Hellstern P
    Vox Sang; 2005 Apr; 88(3):189-95. PubMed ID: 15787729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of donation frequency on donor health in blood donors donating plasma by plasmapheresis: study protocol for a randomized controlled trial.
    Haugen M; Magnussen K; Aarsland TE; Nissen-Meyer LSH; Strand TA
    Trials; 2024 Mar; 25(1):175. PubMed ID: 38468338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum IgG and IgM levels in new and regular long-term plasmapheresis donors.
    Burgin M; Hopkins G; Moore B; Nasser J; Richardson A; Minchinton R
    Med Lab Sci; 1992 Dec; 49(4):265-70. PubMed ID: 1339930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of different intensities of regular donor plasmapheresis on humoral and cellular immunity, red cell and iron metabolism, and cardiovascular risk markers.
    Tran-Mi B; Storch H; Seidel K; Schulzki T; Haubelt H; Anders C; Nagel D; Siegler KE; Vogt A; Seiler D; Hellstern P
    Vox Sang; 2004 Apr; 86(3):189-97. PubMed ID: 15078254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Offering new and returned donors the option to give plasma: implications for donor retention and donor adverse events.
    Thijsen A; Davison TE; Speedy J; Hoad V; Masser B
    Vox Sang; 2021 Mar; 116(3):273-280. PubMed ID: 32702163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Demography and donation frequencies of blood and plasma donor populations in Germany. Update 2010 and 5-year comparison].
    Ritter S; Hamouda O; Offergeld R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Aug; 55(8):914-22. PubMed ID: 22842884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of Plasmapheresis in Donors with Low IgG Levels: Results of a Prospective, Controlled Multicentre Study.
    Moog R; Laitinen T; Taborski U
    Transfus Med Hemother; 2022 Sep; 49(5):271-279. PubMed ID: 37969863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of repeated blood donations on the iron status of Iranian blood donors attending the Iranian blood transfusion organization.
    Djalali M; Neyestani TR; Bateni J; Siassi F
    Int J Vitam Nutr Res; 2006 May; 76(3):132-7. PubMed ID: 17048192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk prediction of iron deficiency for plasmapheresis donors in China: Development and validation of a prediction model.
    Xiao G; Li C; Chen Y; Zhao P; Li W; Xiao H; Yang Y; Zhang Y; Zhou R; Liu A; Liu L; Du L; Xiang Q; Yang J; Wang Y
    Vox Sang; 2024 Feb; 119(2):144-154. PubMed ID: 38152043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of haemoglobin monitoring in apheresis plasma donors: A retrospective cohort study in Québec, Canada.
    Lewin A; Germain M; Renaud C; Robitaille N; Latour C
    Vox Sang; 2023 Dec; 118(12):1041-1045. PubMed ID: 37673797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term return and donation pattern of those who begin donating at different ages: A retrospective cohort analysis of blood donors in Australia.
    Priyono A; Masser BM; Dyda A; Davison TE; Irving DO; Karki S
    Transfusion; 2021 Mar; 61(3):799-810. PubMed ID: 33179790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel approach to increasing inventory with the current panel: increasing donation frequency by asking for a different blood product.
    Bagot KL; Masser BM; White KM
    Transfusion; 2015 Jun; 55(6):1294-302. PubMed ID: 25652648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bringing new plasma donors back: testing the efficacy of telephone and e-mail communications with first-time donors.
    Thorpe R; Masser BM; Nguyen L; Gemelli CN; Davison TE
    Transfusion; 2020 Jul; 60(7):1463-1469. PubMed ID: 32319685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective multicentre study of the effect of voluntary plasmapheresis on plasma cholesterol levels in donors.
    Rosa-Bray M; Wisdom C; Wada S; Johnson BR; Grifols-Roura V; Grifols-Lucas V
    Vox Sang; 2013 Aug; 105(2):108-15. PubMed ID: 23517282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor safety in an individualized plasmapheresis program - Results of an interim analysis.
    Taborski U; Laitinen T
    Transfus Apher Sci; 2022 Oct; 61(5):103446. PubMed ID: 35461780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of plasmapheresis on IgG and albumin].
    Flesland O; Halvorsen R; Solheim BG; Orjasaeter H
    Tidsskr Nor Laegeforen; 1990 Jun; 110(15):1936-7. PubMed ID: 2363163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the plasmapheresis donor in a voluntary, nonremunerated environment.
    Bove LL; Bednall T; Masser B; Buzza M
    Transfusion; 2011 Nov; 51(11):2411-24. PubMed ID: 21564104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.